experimental therapy

Some forms of treatment such as mesothelioma of the drug Alimta ®, gene therapy, immunotherapy, photodynamic therapy and multimodality therapy are still in their experimental stages. We invite you to read the following section on experimental therapies for mesothelioma malignant.
Drug Therapy

The Alimta ®, a new type of cancer treatment being developed by Eli Lilly, the first treatment to significantly increase the length of survival and ameliorate symptoms of the disease. The trial, which was presented at one of the largest against the fatal disease, at the annual meeting of the American Society of Clinical Oncologists.  

There are many strategies of gene therapy currently under study. Although the results in experiments on animals are still disappointed remarkable people. Other agents such as onconase, Thalidomide, lovastatin used as single therapy or in conjunction with chemotherapy to different results.

Click here to browse through gene therapy related to medical literature, articles and Abstracts.
Immunotherapy

The therapy involves removing a patient’s cells, activation by exposure to cytokines and reinstillatin into the peritoneum, accompanied by additional chemotherapy. In some cases try this form of treatment resulted in significant shrinkage of the tumor. However most patients who had early stage disease, and general recommendations are difficult to do so prior to further research.

Click here to browse through the immunotherapy of literature, medical goods and Abstracts.
Photodynamic Therapy

I question the use of drug therapy makes cancer cells sensitive to the particular Wavelength Light. The drug is administered before the surgical procedure. The results were disappointed, and no survival benefit has been shown in studies to date.  
Multimodality Therapy

Doctors are always learning more about how best to treat patients with mesotheliomas. The roles of radiation therapy, surgery, and chemotherapy in the treatment of mesothelioma-A debate. Some treatments use a combination of radiation therapy, surgery, and chemotherapy, called multimodality therapy, are now being studied and can provide the most promising option for some patient

mesothelioma treatment by stage

Treatment by Stage


Unlike the protocol for treatment of mesothelioma based on a patient’s situation to progress at the time of diagnosis. Provided below is a sample of the types of treatment that patients mesothelioma pleural them at various stages of the disease. We have identified the stages of using the staging system Butchart.
Stage I Mesothelioma Treatment


mesothelioma-treatment

Surgical intervention is most commonly recommended for patients mesothelioma diagnosis pleural at Stage I. These procedures are likely to make a pleurectomy / decortication or extrapleural pneumonectomy. Post surgery, other doctors may consider the patient to determine whether chemotherapy or radiation treatment is necessary. Is often determined by stage I mesothelioma is not required of adjunct therapies.
Phase II, III Mesothelioma Treatment

When mesothelioma can not progress to stages II and III of the cancer cured. At the stages of treatment focuses on mitigating the severity of symptoms and to keep the patient as comfortable as possible in order to Optimize quality of life. For example, if there is fluid build up in the great chest the doctor may order that it be drained. In addition, there may be instances when removing some or all of the tumor and / or treatments will have chemo or radiation is being provided symptom relief. Clinical trials may on some of the larger cancer centers in the country also offer different treatment options for patients in stages.
Stage IV Mesothelioma Treatment

When patients are diagnosed with mesothelioma stage IV, the prognóis is very unfavorable. At this stage, the cancer has usually metastasized throughout the body to other organs and that steps II and III, can not be cured. In this phase succeeds, signals generally increase in intensity and the pain management focused primarily on the medical staff. Therapies such as radiation and chemotherapy are not usually available at this stage unless they are required to support the objectives of pain management. Oftentimes families that find it most helpful to seek additional support through the local Hospice program. Hospice programs focus on providing patient care, pain management protocol development and provide support for both patients and family members at the time difficult. Can patients with stage IV mesothelioma also interested to participate in clinical trials is available at specialized cancer hospitals and centers to say and are encouraged to seek the programs if desired.

prognosis mesothelioma

Prognóis Mesothelioma is determined by physical examination and the results of a number of medical tests designed to evaluate the rare asbestos cancer. When a final decision prognóis mesothelioma, then this rare and aggressive cancer treatment is possible, start.

Like most cancers, depending prognóis this disease is often the way it is diagnosed early and how aggressively they should. Early diagnosis and treatment is most important in search of mesothelioma prognóis favorable.

Stage of disease at diagnosis crucial factor in developing the forecast of the patient. As with every type of cancer is, early detection is important, but this was true especially mesothelioma. Since, in general, resist cure mesothelioma, doctors can more effectively manage the disease if they are involved in it early.

Unfortunately, mesothelioma is difficult to “stage” than other types of cancer. This is true for several reasons: they are as rare and just because its initial symptoms are subtle progress normally when diagnosed, making it difficult stage.

Prognóis varies from case to case Mesothelioma, and worse the longer the story with the cancer is left undiscovered. When mesothelioma reached a later stage, and disease spreads to other areas of the body, there is no cure.

There were some other indicators, a iompú in towards a mesothelioma prognóis more favorable. Was found to be the lack of weight loss and lack of visceral involvement of the pleura in clinical studies indicate that cancer was as extensive.

There are other factors that could affect the prognóis mesothelioma, as well as to stage cancer. One is how well you generally. Doctors are way to measure it. They call it performance status “. A score 0 means you can fully look after yourself. A score 1 means that you can do most things for you, but you must help. Scores continue going up, depending on how much you need.

Pathophysiology

The mesothelium consists of a single layer of flattened to cuboidal cells forming the epithelial lining of the serous cavities of the body including the peritoneal, pericardial and pleural cavities. Deposition of asbestos fibers in the parenchyma of the lung may result in the penetration of the visceral pleura from where the fiber can then be carried to the pleural surface, thus leading to the development of malignant mesothelial plaques. The processes leading to the development of peritoneal mesothelioma remain unresolved, although it has been proposed that asbestos fibers from the lung are transported to the abdomen and associated organs via the lymphatic system. Additionally, asbestos fibers may be deposited in the gut after ingestion of sputum contaminated with asbestos fibers.

Pleural contamination with asbestos or other mineral fibers has been shown to cause cancer. Long thin asbestos fibers (blue asbestos, amphibole fibers) are more potent carcinogens than "feathery fibers" (chrysotile or white asbestos fibers). However, there is now evidence that smaller particles may be more dangerous than the larger fibers. They remain suspended in the air where they can be inhaled, and may penetrate more easily and deeper into the lungs. "We probably will find out a lot more about the health aspects of asbestos from [the World Trade Center attack], unfortunately," said Dr. Alan Fein, chief of pulmonary and critical-care medicine at North Shore-Long Island Jewish Health System. Dr. Fein has treated several patients for "World Trade Center syndrome" or respiratory ailments from brief exposures of only a day or two near the collapsed buildings.

Mesothelioma development in rats has been demonstrated following intra-pleural inoculation of phosphorylated chrysotile fibers. It has been suggested that in humans, transport of fibers to the pleura is critical to the pathogenesis of mesothelioma. This is supported by the observed recruitment of significant numbers of macrophages and other cells of the immune system to localized lesions of accumulated asbestos fibers in the pleural and peritoneal cavities of rats. These lesions continued to attract and accumulate macrophages as the disease progressed, and cellular changes within the lesion culminated in a morphologically malignant tumor.

Experimental evidence suggests that asbestos acts as a complete carcinogen with the development of mesothelioma occurring in sequential stages of initiation and promotion. The molecular mechanisms underlying the malignant transformation of normal mesothelial cells by asbestos fibers remain unclear despite the demonstration of its oncogenic capabilities. However, complete in vitro transformation of normal human mesothelial cells to malignant phenotype following exposure to asbestos fibers has not yet been achieved. In general, asbestos fibers are thought to act through direct physical interactions with the cells of the mesothelium in conjunction with indirect effects following interaction with inflammatory cells such as macrophages.

Analysis of the interactions between asbestos fibers and DNA has shown that phagocytosed fibers are able to make contact with chromosomes, often adhering to the chromatin fibers or becoming entangled within the chromosome. This contact between the asbestos fiber and the chromosomes or structural proteins of the spindle apparatus can induce complex abnormalities. The most common abnormality is monosomy of chromosome 22. Other frequent abnormalities include structural rearrangement of 1p, 3p, 9p and 6q chromosome arms.

Common gene abnormalities in mesothelioma cell lines include deletion of the tumor suppressor genes:
Neurofibromatosis type 2 at 22q12
P16INK4A
P14ARF

Asbestos has also been shown to mediate the entry of foreign DNA into target cells. Incorporation of this foreign DNA may lead to mutations and oncogenesis by several possible mechanisms:
Inactivation of tumor suppressor genes
Activation of oncogenes
Activation of proto-oncogenes due to incorporation of foreign DNA containing a promoter region
Activation of DNA repair enzymes, which may be prone to error
Activation of telomerase
Prevention of apoptosis

Asbestos fibers have been shown to alter the function and secretory properties of macrophages, ultimately creating conditions which favour the development of mesothelioma. Following asbestos phagocytosis, macrophages generate increased amounts of hydroxyl radicals, which are normal by-products of cellular anaerobic metabolism. However, these free radicals are also known clastogenic and membrane-active agents thought to promote asbestos carcinogenicity. These oxidants can participate in the oncogenic process by directly and indirectly interacting with DNA, modifying membrane-associated cellular events, including oncogene activation and perturbation of cellular antioxidant defences.

Asbestos also may possess immunosuppressive properties. For example, chrysotile fibres have been shown to depress the in vitro proliferation of phytohemagglutinin-stimulated peripheral blood lymphocytes, suppress natural killer cell lysis and significantly reduce lymphokine-activated killer cell viability and recovery. Furthermore, genetic alterations in asbestos-activated macrophages may result in the release of potent mesothelial cell mitogens such as platelet-derived growth factor (PDGF) and transforming growth factor-β (TGF-β) which in turn, may induce the chronic stimulation and proliferation of mesothelial cells after injury by asbestos fibres.

Diagnosis

Diagnosing mesothelioma is often difficult, because the symptoms are similar to those of a number of other conditions. Diagnosis begins with a review of the patient's medical history. A history of exposure to asbestos may increase clinical suspicion for mesothelioma. A physical examination is performed, followed by chest X-ray and often lung function tests. The X-ray may reveal pleural thickening commonly seen after asbestos exposure and increases suspicion of mesothelioma. A CT (or CAT) scan or an MRI is usually performed. If a large amount of fluid is present, abnormal cells may be detected by cytology if this fluid is aspirated with a syringe. For pleural fluid this is done by a pleural tap or chest drain, in ascites with an paracentesis or ascitic drain and in a pericardial effusion with pericardiocentesis. While absence of malignant cells on cytology does not completely exclude mesothelioma, it makes it much more unlikely, especially if an alternative diagnosis can be made (e.g. tuberculosis, heart failure).

If cytology is positive or a plaque is regarded as suspicious, a biopsy is needed to confirm a diagnosis of mesothelioma. A doctor removes a sample of tissue for examination under a microscope by a pathologist. A biopsy may be done in different ways, depending on where the abnormal area is located. If the cancer is in the chest, the doctor may perform a thoracoscopy. In this procedure, the doctor makes a small cut through the chest wall and puts a thin, lighted tube called a thoracoscope into the chest between two ribs. Thoracoscopy allows the doctor to look inside the chest and obtain tissue samples.

If the cancer is in the abdomen, the doctor may perform a laparoscopy. To obtain tissue for examination, the doctor makes a small incision in the abdomen and inserts a special instrument into the abdominal cavity. If these procedures do not yield enough tissue, more extensive diagnostic surgery may be necessary.

 

CT scan of a patient with mesothelioma, coronal section (the section follows the plane that divides the body in a front and a back half). The mesothelioma is indicated by yellow arrows, the central pleural effusion (fluid collection) is marked with a yellow star. Red numbers: (1) right lung, (2) spine, (3) left lung, (4) ribs, (5) descending part of the aorta, (6) spleen, (7) left kidney, (8) right kidney, (9) liver.

Signs and symptoms

Symptoms of mesothelioma may not appear until 20 to 50 years after exposure to asbestos. Shortness of breath, cough, and pain in the chest due to an accumulation of fluid in the pleural space are often symptoms of pleural mesothelioma.

Symptoms of peritoneal mesothelioma include weight loss and cachexia, abdominal swelling and pain due to ascites (a buildup of fluid in the abdominal cavity). Other symptoms of peritoneal mesothelioma may include bowel obstruction, blood clotting abnormalities, anemia, and fever. If the cancer has spread beyond the mesothelium to other parts of the body, symptoms may include pain, trouble swallowing, or swelling of the neck or face.

These symptoms may be caused by mesothelioma or by other, less serious conditions.

Mesothelioma that affects the pleura can cause these signs and symptoms:
@ Chest wall pain
@ Pleural effusion, or fluid surrounding the lung
@ Shortness of breath
@ Fatigue or anemia
@ Wheezing, hoarseness, or cough
@ Blood in the sputum (fluid) coughed up (hemoptysis)

In severe cases, the person may have many tumor masses. The individual may develop a pneumothorax, or collapse of the lung. The disease may metastasize, or spread, to other parts of the body.

Tumors that affect the abdominal cavity often do not cause symptoms until they are at a late stage. Symptoms include:
# Abdominal pain
# Ascites, or an abnormal buildup of fluid in the abdomen
# A mass in the abdomen
# Problems with bowel function
# Weight loss

In severe cases of the disease, the following signs and symptoms may be present:
$ Blood clots in the veins, which may cause thrombophlebitis
$ Disseminated intravascular coagulation, a disorder causing severe    bleeding in many body organs
$ Jaundice, or yellowing of the eyes and skin
$ Low blood sugar level
$ Pleural effusion
$ Pulmonary emboli, or blood clots in the arteries of the lungs
$ Severe ascites

A mesothelioma does not usually spread to the bone, brain, or adrenal glands. Pleural tumors are usually found only on one side of the lungs.

what is mesothelioma?

Mesothelioma is a form of cancer that is almost always caused by exposure to asbestos. In this disease, malignant cells develop in the mesothelium, a protective lining that covers most of the body's internal organs. Its most common site is the pleura (outer lining of the lungs and internal chest wall), but it may also occur in the peritoneum (the lining of the abdominal cavity), the heart, the pericardium (a sac that surrounds the heart) or tunica vaginalis.

Most people who develop mesothelioma have worked on jobs where they inhaled asbestos particles, or they have been exposed to asbestos dust and fiber in other ways. It has also been suggested that washing the clothes of a family member who worked with asbestos can put a person at risk for developing mesothelioma. Unlike lung cancer, there is no association between mesothelioma and smoking, but smoking greatly increases risk of other asbestos-induced cancer. Compensation via asbestos funds or lawsuits is an important issue in mesothelioma (see asbestos and the law).

The symptoms of mesothelioma include shortness of breath due to pleural effusion (fluid between the lung and the chest wall) or chest wall pain, and general symptoms such as weight loss. The diagnosis may be suspected with chest X-ray and CT scan, and is confirmed with a biopsy (tissue sample) and microscopic examination. A thoracoscopy (inserting a tube with a camera into the chest) can be used to take biopsies. It allows the introduction of substances such as talc to obliterate the pleural space (called pleurodesis), which prevents more fluid from accumulating and pressing on the lung. Despite treatment with chemotherapy, radiation therapy or sometimes surgery, the disease carries a poor prognosis. Research about screening tests for the early detection of mesothelioma is ongoing.

Large mesothelioma around the right lung (left side of image) on CT scan